Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
Go back to Ligand to Report First Quarter 2026 Financial Results on May 7, 2026| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 320.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $320.42 | 52 Week High | $139.79 | |||
| Open | $320.42 | 52 Week Low | $82.07 | |||
| Day High | $320.42 | P/E | 745.16 | |||
| Day Low | $320.42 | EPS | $0.43 | |||
| Volume | 5 | |||||

